Contact Us

Phone: 1-866-61-EISAI (1-866-61-34724)

Fax: 1-866-57-EISAI (1-866-57-34724)

Monday - Friday 8AM - 8PM ET


Forms

Patient Assistance Program

Eisai Assistance Program

The Eisai Assistance Program is your dedicated resource to help you minimize payor access and coverage challenges. The Eisai Assistance Program is the first line of resource to provide you with information relating to your patients insurance coverage.

What to expect when you contact the Eisai Assistance Program:

  • Product specific reimbursement information
  • Understanding of coverage, coding and payment issues
  • Insurance verification processing
  • Prior authorization information
  • Provide general guidance for appealing a denied claim
  • Payor policy information

The Eisai Patient Assistance Program (PAP) also provides Eisai medicines at no cost to financially needy patients who meet program eligibility criteria.

Healthcare professionals - To prescreen your patients for eligibility into the Eisai PAP please visit https://www.eisaipatientassistance.com/.

Contact Us:

Eisai Assistance Program
P.O. Box 29231
Phoenix, AZ 85038
Phone: 1-866-61- EISAI (1-866-61- 34724)
Fax: 1-866-57-EISAI (1-866-57- 34724)
Mon-Fri 8AM - 8PM ET

 

Indication

ALOXI® (palonosetron HCl) injection 0.25 mg is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy, and acute nausea and vomiting associated with initial and repeat courses of highly emetogenic chemotherapy.


Important Safety Information:


For more information about ALOXI® please see full Prescribing Information.




Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.

This information is intended for use by our healthcare professionals in the United States only. Eisai Inc. recognizes the Internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here is not appropriate for use outside the United States. This site contains information about products that may have different product labeling in different countries.

ALOXI® is a registered trademark of Helsinn Healthcare SA, Switzerland, used under license.

Distributed and marketed by Eisai Inc. CORP74AR6 ©2012 Eisai Inc. All rights reserved.

This site was last modified on : December 19, 2011 at 5:45pm ET